LD-2 disclosure · 3rd Quarter - Report
ALLIANCE FOR PHARMACY COMPOUNDING
Client
- Description
- Non-profit association promoting the practice of pharmacy compounding
- Location
- Texas · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act
LobbyistsMICHAEL TOMBERLIN · THERESA REED · mr ROBERT DAVID PORE
Covered position (MICHAEL TOMBERLIN): Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
Covered position (mr ROBERT DAVID PORE): Legislative Director, Cong. Jim Turner
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act
LobbyistsMICHAEL TOMBERLIN · THERESA REED · mr ROBERT DAVID PORE
Covered position (MICHAEL TOMBERLIN): Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert
Covered position (mr ROBERT DAVID PORE): Legislative Director, Cong. Jim Turner
TargetedSENATE · HOUSE OF REPRESENTATIVES